BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

AMERIPRISE FINANCIAL INC's Holding History (CIK: 0000820027)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 7,000,000 Value ($000) $7,858 Avg Close — Range —
Q3 2025
Shares 3,500,000 Value ($000) $3,446 Avg Close — Range —
Q2 2025
Shares 12,200,000 Value ($000) $11,358 Avg Close — Range —
Q1 2025
Shares 20,000,000 Value ($000) $17,930 Avg Close — Range —
Q4 2024
Shares 32,000,000 Value ($000) $27,296 Avg Close — Range —
Q3 2024
Shares 32,500,000 Value ($000) $27,138 Avg Close — Range —
Q2 2024
Shares 23,000,000 Value ($000) $18,213 Avg Close — Range —
Q1 2024
Shares 25,500,000 Value ($000) $20,766 Avg Close — Range —
Q4 2023
Shares 25,500,000 Value ($000) $21,596 Avg Close — Range —
Q3 2023
Shares 29,000,000 Value ($000) $21,605 Avg Close — Range —
Q2 2023
Shares 32,200,000 Value ($000) $19,767 Avg Close — Range —
Q1 2023
Shares 48,200,000 Value ($000) $30,720 Avg Close — Range —
Q4 2022
Shares 48,378,000 Value ($000) $17,993 Avg Close — Range —
Q3 2022
Shares 48,378,000 Value ($000) $20,982 Avg Close — Range —
Q2 2022
Shares 48,378,000 Value ($000) $19,773 Avg Close — Range —
Q1 2022
Shares 48,500,000 Value ($000) $22,456 Avg Close — Range —